| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $10.00M | $10.59M | $8.08M | $8.61M | $3.64M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | – | – | – | – | – |
| R&D | $125.90M | $68.39M | $54.92M | $53.44M | $26.24M |
| SG&A | $41.77M | $41.05M | $26.14M | $22.26M | $10.33M |
| Operating Income | -$157.67M | -$98.85M | -$72.98M | -$67.09M | -$32.93M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | – | – |
| Net Income | -$113.63M | -$68.99M | -$58.29M | -$63.06M | -$32.67M |
| EPS (basic) | -1.8300 | -1.2800 | -1.3200 | -1.5200 | -1.3900 |
| EPS (diluted) | -1.8300 | -1.2800 | -1.3200 | -1.5200 | -1.3900 |
| Shares (diluted) | $61.97M | $53.75M | $44.02M | $41.47M | $23.53M |